Scoring system for the prediction of successful peripheral blood stem cell (PBSC) collection in non-Hodgkin's lymphoma (NHL): application in clinical practice
- 1 March 2000
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 25 (5) , 495-499
- https://doi.org/10.1038/sj.bmt.1702201
Abstract
Bone Marrow Transplantation is a high quality, peer-reviewed journal covering all aspects of clinical and basic haemopoietic stem cell transplantation.Keywords
This publication has 20 references indexed in Scilit:
- Randomized comparison of progenitor-cell mobilization using chemotherapy, stem-cell factor, and filgrastim or chemotherapy plus filgrastim alone in patients with ovarian cancer.Journal of Clinical Oncology, 1998
- Enhanced myelotoxicity due to granulocyte colony-stimulating factor administration until 48 hours before the next chemotherapy course in patients with small-cell lung carcinoma.Journal of Clinical Oncology, 1998
- Back-up bone marrow is frequently ineffective in patients with poor peripheral-blood stem-cell mobilization.Journal of Clinical Oncology, 1998
- High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell LymphomaNew England Journal of Medicine, 1997
- Predictors for optimal mobilization and subsequent engraftment of peripheral blood progenitor cells following intermediate dose cyclophosphamide and G-CSFLeukemia Research, 1997
- Ifosfamide, etoposide, cytarabine, and methotrexate as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphomaCancer, 1996
- Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1995
- Recombinant Interferon Alfa-2b Combined with a Regimen Containing Doxorubicin in Patients with Advanced Follicular LymphomaNew England Journal of Medicine, 1993
- A Predictive Model for Aggressive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Salvage Therapy with Methyl-gag, High-Dose Ara-C, M-Amsa, and Ifosfamide (MAMI) for Recurrent or Refractory LymphomaCancer Investigation, 1990